March 29 (Reuters) - Kazia Therapeutics Ltd KZA.AX :
* ENTERED INTO LICENSING AGREEMENT WITH SIMCERE PHARMACEUTICAL GROUP LTD
* AGREEMENT TO DEVELOP AND COMMERCIALISE CO'S NEW DRUG, PAXALISIB, IN GREATER CHINA
* UNDER TERMS OF AGREEMENT, KAZIA WILL RECEIVE AN UPFRONT PAYMENT OF US$11 MILLION